Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1976-6-2
|
pubmed:abstractText |
An intravenous dosage form of dichlorotetrafluoroethane, a common fluorocarbon aerosol propellant, was formulated in polyethylene glycol 400 for single dosing to unanesthetized dogs. A three-compartment open model was proposed for the disposition of this compound in dogs, with average half-lives of 1.3, 9.6, and 50.8 min for the three disposition phases. An analysis of tissue compartment distribution following a single dose showed that it took about 2 hr to achieve pseudo-distribution equilibration, following which more than 90% of the propellant remaining in the body was retained in the tissue compartments. Pulmonary clearance and volumes of distribution were calculated considering the first-pass effect through the lungs. The volume of distribution was approximately 10 times the body weight in terms of blood concentration, and about 84% of the propellant was cleared from the blood passing through the lungs in each cycle.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0022-3549
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
65
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
60-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1255437-Aerosol Propellants,
pubmed-meshheading:1255437-Aerosols,
pubmed-meshheading:1255437-Animals,
pubmed-meshheading:1255437-Dogs,
pubmed-meshheading:1255437-Hydrocarbons, Halogenated,
pubmed-meshheading:1255437-Injections, Intravenous,
pubmed-meshheading:1255437-Kinetics,
pubmed-meshheading:1255437-Lung,
pubmed-meshheading:1255437-Male,
pubmed-meshheading:1255437-Models, Biological
|
pubmed:year |
1976
|
pubmed:articleTitle |
Fluorocarbon aerosol propellants X: pharmacokinetics of dichlorotetrafluoroethane in dogs.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.
|